litlas
Log inCreate account

Robert H. Shoemaker

Active 1985–2024

69
Papers
21,480
Citations
50
h-index
65
i10-index

Citations

Citations per year for Robert H. Shoemaker1985: 1 citations1986: 2 citations1987: 3 citations1988: 7 citations1989: 18 citations1990: 29 citations1991: 40 citations1992: 42 citations1993: 36 citations1994: 28 citations1995: 34 citations1996: 49 citations1997: 72 citations1998: 63 citations1999: 86 citations2000: 77 citations2001: 100 citations2002: 83 citations2003: 136 citations2004: 157 citations2005: 170 citations2006: 179 citations2007: 153 citations2008: 182 citations2009: 172 citations2010: 190 citations2011: 166 citations2012: 218 citations2013: 151 citations2014: 171 citations2015: 170 citations2016: 145 citations2017: 121 citations2018: 111 citations2019: 414 citations2020: 402 citations2021: 355 citations2022: 270 citations2023: 216 citations2024: 368 citations2025: 169 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,833 citing papers, 26.8% of this breakdownChina: 585 citing papers, 8.5% of this breakdownUnited Kingdom: 389 citing papers, 5.7% of this breakdownGermany: 331 citing papers, 4.8% of this breakdownItaly: 274 citing papers, 4% of this breakdownIndia: 234 citing papers, 3.4% of this breakdownEgypt: 228 citing papers, 3.3% of this breakdownJapan: 190 citing papers, 2.8% of this breakdownCanada: 173 citing papers, 2.5% of this breakdownFrance: 172 citing papers, 2.5% of this breakdownSpain: 147 citing papers, 2.2% of this breakdownSouth Korea: 141 citing papers, 2.1% of this breakdown
0%26.8%Other 31.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology39.8%
  • Medicine29.7%
  • Computer Science8%
  • Chemistry6.9%
  • Immunology and Microbiology4.1%
  • Agricultural and Biological Sciences3%
  • Other8.5%

Topics

  • Computational Drug Discovery Methods4%
  • Cancer, Hypoxia, and Metabolism3.3%
  • Synthesis and biological activity2.4%
  • Cancer therapeutics and mechanisms2.2%
  • Bioinformatics and Genomic Networks1.5%
  • Cancer Cells and Metastasis1.3%
  • Other85.3%

Coauthors

All papers

Open in search
  1. The NCI60 human tumour cell line anticancer drug screen

    Authors: Robert H. Shoemaker - Nature reviews. Cancer 2006 cited by 2,672

  2. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

    Authors: Michael C. Alley, Dominic A. Scudiero, Anne Monks, Miriam L. Hursey, Maciej Czerwiński, Donald L. Fine, Betty J. Abbott, Joseph G. Mayo, Robert H. Shoemaker, Michael R. Boyd - 1988 cited by 3,104

  3. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

    Authors: Anne Monks, Dominic A. Scudiero, Philip Skehan, Robert H. Shoemaker, Kenneth D. Paull, David T. Vistica, Curtis Hose, James W. Langley, P. Cronise, Anne Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, Marie Boyd - JNCI Journal of the National Cancer Institute 1991 cited by 3,274

  4. Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer

    Authors: Mofei Huang, Donghai Xiong, Jing Pan, Qi Zhang, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Luis M. Montuenga, Yian Wang, Barbara S. Slusher, Ming You - Advanced Science 2022 cited by 71

  5. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

    Authors: Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull, Anne Monks, Sean Tierney, T H Nofziger, Michael J. Currens, D A Seniff, Michael R. Boyd - 1988 cited by 2,365

  6. Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity

    Authors: Dehe Kong, Eun‐Jung Park, Andrew G. Stephen, Maura Calvani, John H. Cardellina, Anne Monks, Robert J. Fisher, Robert H. Shoemaker, Giovanni Melillo - Cancer Research 2005 cited by 513

  7. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model

    Authors: Johannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, Jason D. Marshall, Alejandro Hernandez‐Sanchez, Katharina Urban, Mark D. Long, Eduardo Cortes, Elena Tosti, Eva‐Maria Katzenmaier, Yurong Song, Ali Elsaadi, Nan Deng, Eduardo Vilar, Vera Fuchs, Nina Nelius, Yan P. Yuan, Aysel Ahadova, Shizuko Sei, Robert H. Shoemaker, Asad Umar, Lei Wei, Song Liu, Peer Bork, Winfried Edelmann, Magnus von Knebel Doeberitz, Steven M. Lipkin, Matthias Kloor - Gastroenterology 2021 cited by 114

  8. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress

    Authors: Monika Aggarwal, Joshua A. Sommers, Robert H. Shoemaker, Robert M. Brosh - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 202

  9. Werner Syndrome Helicase Has a Critical Role in DNA Damage Responses in the Absence of a Functional Fanconi Anemia Pathway

    Authors: Monika Aggarwal, Taraswi Banerjee, Joshua A. Sommers, Chiara Iannascoli, Pietro Pichierri, Robert H. Shoemaker, Robert M. Brosh - Cancer Research 2013 cited by 88

  10. Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator

    Authors: Jing Pan, Qi Zhang, Katie Palen, Li Wang, Lifen Qiao, Bryon D. Johnson, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Ming You - EBioMedicine 2019 cited by 59

  11. WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells

    Authors: Arindam Datta, Kajal Biswas, Joshua A. Sommers, Haley Thompson, Sanket Awate, Claudia M. Nicolae, Tanay Thakar, George‐Lucian Moldovan, Robert H. Shoemaker, Shyam K. Sharan, Robert M. Brosh - Nature Communications 2021 cited by 50

  12. Pulmonary Aerosol Delivery of Let‐7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment

    Authors: Qi Zhang, Jing Pan, Donghai Xiong, Yian Wang, Mark Steven Miller, Shizuko Sei, Robert H. Shoemaker, Alberto Izzotti, Ming You - Advanced Science 2021 cited by 33

  13. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

    Authors: Michael R. Boyd, Kirk R. Gustafson, James B. McMahon, Robert H. Shoemaker, Barry R. O’Keefe, Toshiyuki Mori, Robert J. Gulakowski, Lin Wu, Maria I Rivera, Carolyn M. Laurençot, Michael J. Currens, John H. Cardellina, Robert W. Buckheit, Peter L. Nara, Lewis K. Pannell, Raymond C. Sowder, Louis E. Henderson - Antimicrobial Agents and Chemotherapy 1997 cited by 614

  14. Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

    Authors: Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani, Robert H. Shoemaker, Carolyn J.M. Best, Mones Abu‐Asab, Jennifer Borojerdi, Noel A. Warfel, Erin R. Gardner, Matthew Danish, M. Christine Hollander, Shigeru Kawabata, Maria Tsokos, William D. Figg, Patricia S. Steeg, Phillip A. Dennis - Clinical Cancer Research 2007 cited by 326

  15. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa

    Authors: Laura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, Prashant V. Bommi, Alejandro Francisco‐Cruz, Luisa M. Solis, Patrick M Lynch, Ramona M. Lim, Elena M. Stoffel, Priyanka Kanth, N. Jewel Samadder, Maureen E. Mork, Melissa W. Taggart, Ginger L. Milne, Lawrence J. Marnett, Lana A. Vornik, Diane D. Liu, María V. Revuelta, Kyle Chang, Y. Nancy You, Levy Kopelovich, Ignacio I. Wistuba, J Jack Lee, Shizuko Sei, Robert H. Shoemaker, Éva Szabó, Ellen Richmond, Asad Umar, Marjorie Perloff, Powel H. Brown, Steven M. Lipkin, Eduardo Vilar - Gut 2020 cited by 62

  16. Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists

    Authors: Athina Zacharia, Erin Harberts, Sarah Valencia, Breana Myers, Chelsea Sanders, Akshay Jain, Nicholas R. Larson, C. Russell Middaugh, William D. Picking, Simone Difilippantonio, Reinhard Kirnbauer, Richard B.S. Roden, Lígia A. Pinto, Robert H. Shoemaker, Robert K. Ernst, Jason D. Marshall - Vaccine 2020 cited by 34

  17. Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA

    Authors: Jing Pan, Yao Chen, Qi Zhang, Achia Khatun, Katie Palen, Gang Xin, Li Wang, Chuanjia Yang, Bryon D. Johnson, Charles R. Myers, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Weiguo Cui, Ming You - Communications Biology 2021 cited by 27

  18. Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

    Authors: Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes, Anne Monks, Dominic A. Scudiero, Larry Rubinstein, Jacqueline Plowman, Michael R. Boyd - JNCI Journal of the National Cancer Institute 1989 cited by 969

  19. The Metastasis-Associated Gene S100A4 Is a Novel Target of β-catenin/T-cell Factor Signaling in Colon Cancer

    Authors: Ulrike Stein, Franziska Arlt, Wolfgang Walther, Janice Smith, Todd Waldman, Erik Harris, Susan D. Mertins, Claus W. Heizmann, David Allard, Walter Birchmeier, Peter M. Schlag, Robert H. Shoemaker - Gastroenterology 2006 cited by 211

  20. Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer

    Authors: Holli A. Loomans‐Kropp, Yurong Song, Manish Gala, Aparna R. Parikh, Emily E. Van Seventer, Rocio Alvarez, Megan P. Hitchins, Robert H. Shoemaker, Asad Umar - Cancer Research Communications 2022 cited by 45

  21. Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention

    Authors: Sang Beom Lee, Pan Jing, Donghai Xiong, Katie Palen, Bryon D. Johnson, Ronald A. Lubet, Robert H. Shoemaker, Jeffrey E. Green, Romaine I. Fernando, Shizuko Sei, Ming You, Yian Wang - npj Precision Oncology 2023 cited by 22

  22. Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer

    Authors: Ulrike Sack, Wolfgang Walther, Dominic A. Scudiero, M. Selby, Dennis Kobelt, M Lemm, Iduna Fichtner, P. M. Schlag, Robert H. Shoemaker, Ulrike Stein - JNCI Journal of the National Cancer Institute 2011 cited by 213

  23. Anticancer Specificity of Some Ellipticinium Salts against Human Brain Tumors in vitro

    Authors: Edward M. Acton, V. L. Narayanan, Prabhakar Risbood, Robert H. Shoemaker, David T. Vistica, Michael R. Boyd - Journal of Medicinal Chemistry 1994 cited by 125

  24. Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

    Authors: Annamaria Rapisarda, Badarch Uranchimeg, Olivier Sordet, Yves Pommier, Robert H. Shoemaker, Giovanni Melillo - Cancer Research 2004 cited by 299